JO
MGRM

John Overdeck’s Monogram Orthopaedics MGRM Stock Holding History

John Overdeck’s Portfolio MGRM Stock Details MGRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,235
Closed -$44.8K – 3390
2025
Q1 		$44.8K Buy
+15,235
New +$40.3K ﹤0.01% 3055

Other funds holding MGRM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FPAS
Focus Partners Advisor Solutions Saint Louis, Missouri $11.8B AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

John Overdeck's MGRM Position: Q2 2025 in Review

John Overdeck sold out of Monogram Orthopaedics (MGRM) in Q2 2025, closing a stake of 15,235 shares — an estimated $44.8K sold.

John Overdeck first reported a position in MGRM in Q1 2025 and held it in 1 quarter. The position peaked at $44.8K in Q1 2025. 49 funds tracked by Wall St. Rank hold MGRM as of Q2 2025.

  • John Overdeck reported no remaining Monogram Orthopaedics position as of Q2 2025 after selling out during the quarter.
  • John Overdeck sold 15,235 Monogram Orthopaedics shares in Q2 2025, an estimated $44.8K.
  • John Overdeck first reported a position in Monogram Orthopaedics in Q1 2025 and held it in 1 quarter.
  • John Overdeck's Monogram Orthopaedics position peaked at $44.8K in Q1 2025.
  • 49 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.